- If you are wondering whether Tenet Healthcare at around US$199.63 is still offering value or has already priced in its story, this breakdown is for you.
- The stock has recently seen a 5.7% decline over the last 7 days and a 13.2% decline over the last 30 days, while the 1 year return of 52.6% and very large 3 year and 5 year returns keep longer term holders focused.
- Recent headlines have focused on Tenet Healthcare as investors reassess hospital and healthcare operators, with attention on how these businesses are positioned within the broader sector. This context helps explain why short term price moves can look different to the longer term return record.
- Despite the recent share price pullback, Tenet Healthcare currently scores 6 out of 6 on our valuation checks. The next sections will compare what different valuation methods say about that result, and will also point to an even more useful way to think about value at the end of the article.
Approach 1: Tenet Healthcare Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model estimates what a company could be worth by projecting its future cash flows and discounting them back to today using a required rate of return. It aims to answer what those future cash flows are worth in current dollars.
For Tenet Healthcare, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The company’s latest twelve month free cash flow is about US$2.62b. Analyst inputs and extrapolated estimates then project annual free cash flows through to 2035, with the 2035 figure sitting at about US$2.71b according to the model’s ten year projection path.
Based on discounting those projected cash flows back to today, the model produces an estimated intrinsic value of about US$623.87 per share. When compared with the current share price around US$199.63, the DCF output indicates the stock is trading at a 68.0% discount to this estimate, which screens as materially undervalued under this method.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Tenet Healthcare is undervalued by 68.0%. Track this in your watchlist or portfolio, or discover 58 more high quality undervalued stocks.
Approach 2: Tenet Healthcare Price vs Earnings
For profitable companies, the P/E ratio is a handy way to link what you pay for each share to the earnings that each share generates. It lets you quickly see how much investors are currently paying for US$1 of earnings.
What counts as a normal or fair P/E depends on how the market views a company’s growth prospects and risk. Higher expected growth and lower perceived risk tend to support a higher P/E, while lower growth expectations or higher risk usually line up with a lower P/E.
Tenet Healthcare currently trades on a P/E of 12.34x. That is well below the Healthcare industry average of about 21.41x and also below the peer group average of 21.61x. Simply Wall St’s Fair Ratio framework goes a step further by estimating what a more tailored P/E could look like for Tenet Healthcare, given factors such as its earnings growth profile, industry, profit margins, market cap and risk. This produces a Fair Ratio of 22.54x, which can be more informative than a simple peer or industry comparison because it adjusts for the company’s own characteristics.
With the actual P/E of 12.34x sitting well below the Fair Ratio of 22.54x, the shares screen as undervalued on this metric.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Tenet Healthcare Narrative
Earlier it was mentioned that there is an even better way to think about valuation. On Simply Wall St this comes through Narratives, where you combine your view of Tenet Healthcare’s story with your own revenue, earnings and margin assumptions to build a forecast, translate that into a Fair Value, and then compare it with the current price to decide whether the stock looks attractive or stretched, all inside the Community page that millions of investors use.
Each Narrative ties the business story to the numbers and then to a Fair Value. It updates automatically when new earnings, guidance or news are added, so your view does not go stale just because the headline price moved.
For Tenet Healthcare, one investor might lean toward a higher Fair Value such as US$288.0 based on expectations for factors like outpatient growth, margins around 6.9% and a future P/E near 14.7x. Another might anchor closer to US$137.0 using more cautious assumptions for revenue growth, profit margins around 5.0% and a lower implied P/E. Narratives make those differences in expectations visible so you can decide which story you find more reasonable.
Do you think there's more to the story for Tenet Healthcare? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com